|
Adams, J.M. and Cory, S. (1998) The Bcl-2 protein family: arbiters of cell survival. Science, 281, 1322-1326. Ben-Porath, I., Kozak, C.A. and Benvenisty, N. (1998) Chromosomal mapping of Tmp (Emp1), Xmp (Emp2), and Ymp (Emp3), genes encoding membrane proteins related to Pmp22. Genomics, 49, 443-447. Berditchevski, F. (2001) Complexes of tetraspanins with integrins: more than meets the eye. J Cell Sci, 114, 4143-4151. Chu, Y.W., Yang, P.C., Yang, S.C., Shyu, Y.C., Hendrix, M.J., Wu, R. and Wu, C.W. (1997) Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am J Respir Cell Mol Biol, 17, 353-360. Dedhar, S. (2000) Cell-substrate interactions and signaling through ILK. Curr Opin Cell Biol, 12, 250-256. Dong, J.T., Lamb, P.W., Rinker-Schaeffer, C.W., Vukanovic, J., Ichikawa, T., Isaacs, J.T. and Barrett, J.C. (1995) KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science, 268, 884-886. Doree, M. and Galas, S. (1994) The cyclin-dependent protein kinases and the control of cell division. Faseb J, 8, 1114-1121. Evans, W.H. and Martin, P.E. (2002) Gap junctions: structure and function (Review). Mol Membr Biol, 19, 121-136. Fabbretti, E., Edomi, P., Brancolini, C. and Schneider, C. (1995) Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A. Genes Dev, 9, 1846-1856. Fernandez, A., Udagawa, T., Schwesinger, C., Beecken, W., Achilles-Gerte, E., McDonnell, T. and D''Amato, R. (2001) Angiogenic potential of prostate carcinoma cells overexpressing bcl-2. J Natl Cancer Inst, 93, 208-213. Forbes, A., Wadehra, M., Mareninov, S., Morales, S., Shimazaki, K., Gordon, L.K. and Braun, J. (2007) The tetraspan protein EMP2 regulates expression of caveolin-1. J Biol Chem. Fu, S., Rogowsky, P., Nover, L. and Scanlon, M.J. (2006) The maize heat shock factor-binding protein paralogs EMP2 and HSBP2 interact non-redundantly with specific heat shock factors. Planta, 224, 42-52. Galbiati, F., Razani, B. and Lisanti, M.P. (2001a) Emerging themes in lipid rafts and caveolae. Cell, 106, 403-411. Galbiati, F., Volonte, D., Liu, J., Capozza, F., Frank, P.G., Zhu, L., Pestell, R.G. and Lisanti, M.P. (2001b) Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism. Mol Biol Cell, 12, 2229-2244. Giehl, K. (2005) Oncogenic Ras in tumour progression and metastasis. Biol Chem, 386, 193-205. Gupta, S. and Knowlton, A.A. (2005) HSP60, Bax, apoptosis and the heart. J Cell Mol Med, 9, 51-58. Jankowski, S.A., Mitchell, D.S., Smith, S.H., Trent, J.M. and Meltzer, P.S. (1994) SAS, a gene amplified in human sarcomas, encodes a new member of the transmembrane 4 superfamily of proteins. Oncogene, 9, 1205-1211. Jetten, A.M. and Suter, U. (2000) The peripheral myelin protein 22 and epithelial membrane protein family. Prog Nucleic Acid Res Mol Biol, 64, 97-129. Kedar, D., Baker, C.H., Killion, J.J., Dinney, C.P. and Fidler, I.J. (2002) Blockade of the epidermal growth factor receptor signaling inhibits angiogenesis leading to regression of human renal cell carcinoma growing orthotopically in nude mice. Clin Cancer Res, 8, 3592-3600. Lavoie, J.N., L''Allemain, G., Brunet, A., Muller, R. and Pouyssegur, J. (1996) Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem, 271, 20608-20616. Leitinger, B. and Hogg, N. (2002) The involvement of lipid rafts in the regulation of integrin function. J Cell Sci, 115, 963-972. Liehr, T., Kuhlenbaumer, G., Wulf, P., Taylor, V., Suter, U., Van Broeckhoven, C., Lupski, J.R., Claussen, U. and Rautenstrauss, B. (1999) Regional localization of the human epithelial membrane protein genes 1, 2, and 3 (EMP1, EMP2, EMP3) to 12p12.3, 16p13.2, and 19q13.3. Genomics, 58, 106-108. Liu, H.S., Chen, C.Y., Lee, C.H. and Chou, Y.I. (1998) Selective activation of oncogenic Ha-ras-induced apoptosis in NIH/3T3 cells. Br J Cancer, 77, 1777-1786. Lobsiger, C.S., Magyar, J.P., Taylor, V., Wulf, P., Welcher, A.A., Program, A.E. and Suter, U. (1996) Identification and characterization of a cDNA and the structural gene encoding the mouse epithelial membrane protein-1. Genomics, 36, 379-387. London, E. and Brown, D.A. (2000) Insolubility of lipids in triton X-100: physical origin and relationship to sphingolipid/cholesterol membrane domains (rafts). Biochim Biophys Acta, 1508, 182-195. Lukas, J., Bartkova, J. and Bartek, J. (1996) Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint. Mol Cell Biol, 16, 6917-6925. Maecker, H.T., Todd, S.C. and Levy, S. (1997) The tetraspanin superfamily: molecular facilitators. Faseb J, 11, 428-442. Melkonian, K.A., Ostermeyer, A.G., Chen, J.Z., Roth, M.G. and Brown, D.A. (1999) Role of lipid modifications in targeting proteins to detergent-resistant membrane rafts. Many raft proteins are acylated, while few are prenylated. J Biol Chem, 274, 3910-3917. Musgrove, E.A. (2006) Cyclins: roles in mitogenic signaling and oncogenic transformation. Growth Factors, 24, 13-19. Rak, J., Yu, J.L., Kerbel, R.S. and Coomber, B.L. (2002) What do oncogenic mutations have to do with angiogenesis/vascular dependence of tumors? Cancer Res, 62, 1931-1934. Sawada, S., Yoshimoto, M., Odintsova, E., Hotchin, N.A. and Berditchevski, F. (2003) The tetraspanin CD151 functions as a negative regulator in the adhesion-dependent activation of Ras. J Biol Chem, 278, 26323-26326. Shaw, R.J. and Cantley, L.C. (2006) Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature, 441, 424-430. Sherr, C.J. (1996) Cancer cell cycles. Science, 274, 1672-1677. Sherr, C.J. (2000) The Pezcoller lecture: cancer cell cycles revisited. Cancer Res, 60, 3689-3695. Sinenko, S.A. and Mathey-Prevot, B. (2004) Increased expression of Drosophila tetraspanin, Tsp68C, suppresses the abnormal proliferation of ytr-deficient and Ras/Raf-activated hemocytes. Oncogene, 23, 9120-9128. Sleiman, R.J., Catchpoole, D.R. and Stewart, B.W. (1998) Drug-induced death of leukaemic cells after G2/M arrest: higher order DNA fragmentation as an indicator of mechanism. Br J Cancer, 77, 40-50. Taylor, V. and Suter, U. (1996) Epithelial membrane protein-2 and epithelial membrane protein-3: two novel members of the peripheral myelin protein 22 gene family. Gene, 175, 115-120. Taylor, V., Welcher, A.A., Program, A.E. and Suter, U. (1995) Epithelial membrane protein-1, peripheral myelin protein 22, and lens membrane protein 20 define a novel gene family. J Biol Chem, 270, 28824-28833. Udagawa, T., Fernandez, A., Achilles, E.G., Folkman, J. and D''Amato, R.J. (2002) Persistence of microscopic human cancers in mice: alterations in the angiogenic balance accompanies loss of tumor dormancy. Faseb J, 16, 1361-1370. Wadehra, M., Dayal, M., Mainigi, M., Ord, T., Iyer, R., Braun, J. and Williams, C.J. (2006a) Knockdown of the tetraspan protein epithelial membrane protein-2 inhibits implantation in the mouse. Dev Biol, 292, 430-441. Wadehra, M., Forbes, A., Pushkarna, N., Goodglick, L., Gordon, L.K., Williams, C.J. and Braun, J. (2005) Epithelial membrane protein-2 regulates surface expression of alphavbeta3 integrin in the endometrium. Dev Biol, 287, 336-345. Wadehra, M., Goodglick, L. and Braun, J. (2004) The tetraspan protein EMP2 modulates the surface expression of caveolins and glycosylphosphatidyl inositol-linked proteins. Mol Biol Cell, 15, 2073-2083. Wadehra, M., Iyer, R., Goodglick, L. and Braun, J. (2002) The tetraspan protein epithelial membrane protein-2 interacts with beta1 integrins and regulates adhesion. J Biol Chem, 277, 41094-41100. Wadehra, M., Natarajan, S., Seligson, D.B., Williams, C.J., Hummer, A.J., Hedvat, C., Braun, J. and Soslow, R.A. (2006b) Expression of epithelial membrane protein-2 is associated with endometrial adenocarcinoma of unfavorable outcome. Cancer, 107, 90-98. Wadehra, M., Su, H., Gordon, L.K., Goodglick, L. and Braun, J. (2003a) The tetraspan protein EMP2 increases surface expression of class I major histocompatibility complex proteins and susceptibility to CTL-mediated cell death. Clin Immunol, 107, 129-136. Wadehra, M., Sulur, G.G., Braun, J., Gordon, L.K. and Goodglick, L. (2003b) Epithelial membrane protein-2 is expressed in discrete anatomical regions of the eye. Exp Mol Pathol, 74, 106-112. Wang, C.X., Wadehra, M., Fisk, B.C., Goodglick, L. and Braun, J. (2001) Epithelial membrane protein 2, a 4-transmembrane protein that suppresses B-cell lymphoma tumorigenicity. Blood, 97, 3890-3895. Weber, J.D., Raben, D.M., Phillips, P.J. and Baldassare, J.J. (1997) Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. Biochem J, 326 ( Pt 1), 61-68. Wilson, H.L., Wilson, S.A., Surprenant, A. and North, R.A. (2002) Epithelial membrane proteins induce membrane blebbing and interact with the P2X7 receptor C terminus. J Biol Chem, 277, 34017-34023. Wu, Z.Z., Chien, C.M., Yang, S.H., Lin, Y.H., Hu, X.W., Lu, Y.J., Wu, M.J. and Lin, S.R. (2006) Induction of G2/M phase arrest and apoptosis by a novel enediyne derivative, THDA, in chronic myeloid leukemia (K562) cells. Mol Cell Biochem, 292, 99-105. Yang, J.J., Kang, J.S. and Krauss, R.S. (1998) Ras signals to the cell cycle machinery via multiple pathways to induce anchorage-independent growth. Mol Cell Biol, 18, 2586-2595.
|